PMID- 24591155 OWN - NLM STAT- MEDLINE DCOM- 20141228 LR - 20211021 IS - 1096-0929 (Electronic) IS - 1096-6080 (Print) IS - 1096-0929 (Linking) VI - 139 IP - 1 DP - 2014 May TI - Catechol-o-methyltransferase and 3,4-(+/-)-methylenedioxymethamphetamine toxicity. PG - 162-73 LID - 10.1093/toxsci/kfu035 [doi] AB - Metabolism of 3,4-(+/-)-methylenedioxymethamphetamine (MDMA) is necessary to elicit its neurotoxic effects. Perturbations in phase I and phase II hepatic enzymes can alter the neurotoxic profile of systemically administered MDMA. In particular, catechol-O-methyltransferase (COMT) plays a critical role in determining the fraction of MDMA that is converted to potentially neurotoxic metabolites. Thus, cytochrome P450 mediated demethylenation of MDMA, or its N-demethylated metabolite, 3,4-(+/-)-methylenedioxyamphetamine, give rise to the catechols, N-methyl-alpha-methyldopamine and alpha-methyldopamine, respectively. Methylation of these catechols by COMT limits their oxidation and conjugation to glutathione, a process that ultimately gives rise to neurotoxic metabolites. We therefore determined the effects of modulating COMT, a critical enzyme involved in determining the fraction of MDMA that is converted to potentially neurotoxic metabolites, on MDMA-induced toxicity. Pharmacological inhibition of COMT in the rat potentiated MDMA-induced serotonin deficits and exacerbated the acute MDMA-induced hyperthermic response. Using a genetic mouse model of COMT deficiency, in which mice lack a functional COMT gene, such mice displayed greater reductions in dopamine concentrations relative to their wild-type (WT) counterparts. Neither WT nor COMT deficient mice were susceptible to MDMA-induced decreases in serotonin concentrations. Interestingly, mice devoid of COMT were far more susceptible to the acute hyperthermic effects of MDMA, exhibiting greater increases in body temperature that ultimately resulted in death. Our findings support the view that COMT plays a pivotal role in determining the toxic response to MDMA. FAU - Herndon, Joseph M AU - Herndon JM AD - Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721. FAU - Cholanians, Aram B AU - Cholanians AB FAU - Lizarraga, Lucina E AU - Lizarraga LE FAU - Lau, Serrine S AU - Lau SS FAU - Monks, Terrence J AU - Monks TJ LA - eng GR - P30 ES006694/ES/NIEHS NIH HHS/United States GR - DA023525/DA/NIDA NIH HHS/United States GR - T32 ES007091/ES/NIEHS NIH HHS/United States GR - 5T32ES007091/ES/NIEHS NIH HHS/United States GR - R01 DA023525/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20140303 PL - United States TA - Toxicol Sci JT - Toxicological sciences : an official journal of the Society of Toxicology JID - 9805461 RN - 0 (Benzophenones) RN - 0 (DNA Primers) RN - 125628-97-9 (Ro 41-0960) RN - 4764-17-4 (3,4-Methylenedioxyamphetamine) RN - EC 2.1.1.6 (Catechol O-Methyltransferase) RN - X4W3ENH1CV (Norepinephrine) SB - IM MH - 3,4-Methylenedioxyamphetamine/*toxicity MH - Animals MH - Base Sequence MH - Benzophenones/pharmacology MH - Catechol O-Methyltransferase/*metabolism MH - Chromatography, High Pressure Liquid MH - DNA Primers MH - Electrochemical Techniques MH - Female MH - Fever/chemically induced MH - Liver/drug effects/enzymology MH - Mice MH - Mice, Inbred C57BL MH - Norepinephrine/blood MH - Rats MH - Rats, Sprague-Dawley PMC - PMC4007109 OTO - NOTNLM OT - 3,4-(+/-)-methylenedioxymethamphetamine OT - catechol-O-methyltransferase OT - hyperthermia EDAT- 2014/03/05 06:00 MHDA- 2014/12/30 06:00 PMCR- 2015/05/01 CRDT- 2014/03/05 06:00 PHST- 2014/03/05 06:00 [entrez] PHST- 2014/03/05 06:00 [pubmed] PHST- 2014/12/30 06:00 [medline] PHST- 2015/05/01 00:00 [pmc-release] AID - kfu035 [pii] AID - 10.1093/toxsci/kfu035 [doi] PST - ppublish SO - Toxicol Sci. 2014 May;139(1):162-73. doi: 10.1093/toxsci/kfu035. Epub 2014 Mar 3.